학술논문

BNT211: a Phase 1 Study to determine the Safety and Efficacy of CLDN6 CAR T Cells and CARVAC-mediated in vivo Expansion in Patients with CLDN6-positive advanced solid Tumors
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; SEP 2022, 45 SUPPL 2, p43-p44, 2p. Supplement: 2
Subject
Language
English
ISSN
22965262